Hydroxyprogesterone heptanoate

Hydroxyprogesterone heptanoate

Clinical data
Trade names	H.O.P, Lutogil A.P., Lutogyl A.P.
ATC code	G03DA03 (WHO)
Identifiers
IUPAC name [(8R,9S,10R,13S,14S,17R)-17-Acetyl-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] heptanoate
Synonyms	17α-Hydroxypregn-4-ene-3,20-dione 17α-heptanoate
CAS Number	4596-16-1
PubChem CID	94296
ChemSpider	85099
ECHA InfoCard	100.022.724
Chemical and physical data
Formula	C28H42O4
Molar mass	442.63068 g/mol
3D model (Jmol)	Interactive image
SMILES CCCCCCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)C
InChI InChI=1S/C28H42O4/c1-5-6-7-8-9-25(31)32-28(19(2)29)17-14-24-22-11-10-20-18-21(30)12-15-26(20,3)23(22)13-16-27(24,28)4/h18,22-24H,5-17H2,1-4H3/t22-,23+,24+,26+,27+,28+/m1/s1 Key:NKJYZYWCGKSMSV-BDPSOKNUSA-N

Hydroxyprogesterone heptanoate (brand names H.O.P., Lutogil A.P., Lutogyl A.P.), or 17α-hydroxyprogesterone heptanoate, also known as hydroxyprogesterone enanthate, is a steroidal progestin of the 17α-hydroxyprogesterone group that was developed by Roussel and Théramex and has been used clinically in France and Monaco. It was a component of the experimental preparation Trophoboline (or Trophobolene), which also contained nandrolone decanoate and estrapronicate. It was also studied or used in Tocogestan, a combination of hydroxyprogesterone heptanoate (200 mg), progesterone (50 mg), and (250 mg) oil for intramuscular injection.